Donald Francis Sinex

Director/Board Member at Gold Avenue Ltd.

74 year

Consumer Services

Health Technology

Non-Energy Minerals

Profile

Mr. Donald F.
Sinex is Independent Director at Immtech Pharmaceuticals, Inc. He is on the Board of Directors at Gold Avenue Ltd.
and Immtech Pharmaceuticals, Inc. He received his undergraduate degree from the University of Delaware, a graduate degree from the University of Miami (Florida), and an MBA from Harvard University.

Donald Francis Sinex active positions

Companies	Position	Start
Gold Avenue Ltd. Gold Avenue Ltd. Other Metals/MineralsNon-Energy Minerals Gold Avenue Ltd. is an investment holding Chinese company that is primarily focused on the production and sale of tin.	Director/Board Member	2009-11-29

All active positions of Donald Francis Sinex

Former positions of Donald Francis Sinex

Companies	Position	End
Immtech Pharmaceuticals, Inc. Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY.	Director/Board Member	-

See the detail of Donald Francis Sinex's experience

Training of Donald Francis Sinex

University of Delaware	Undergraduate Degree
University of Miami	Graduate Degree
Harvard University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Donald Francis Sinex's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Immtech Pharmaceuticals, Inc. Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY.	Health Technology
Gold Avenue Ltd. Gold Avenue Ltd. Other Metals/MineralsNon-Energy Minerals Gold Avenue Ltd. is an investment holding Chinese company that is primarily focused on the production and sale of tin.	Non-Energy Minerals